We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPG icon
101
Simon Property Group
SPG
$71.7B
$575M 0.22%
4,890,860
+931,205
+24% +$103M
ADP icon
102
Automatic Data Processing
ADP
$108B
$557M 0.22%
2,345,057
-95,141
-4% -$23.4M
AZN icon
103
AstraZeneca
AZN
$251B
$548M 0.21%
4,042,341
+316,502
+8% +$39.7M
PYPL icon
104
PayPal
PYPL
$50.9B
$547M 0.21%
7,682,234
+526,872
+7% +$42.2M
NOC icon
105
Northrop Grumman
NOC
$80.5B
$545M 0.21%
999,040
+227,858
+30% +$119M
FIS icon
106
Fidelity National Information Services
FIS
$22B
$540M 0.21%
7,963,921
+1,564,508
+24% +$111M
HZNP
107
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$530M 0.21%
4,658,643
-2,295,927
-33% -$191M
TT icon
108
Trane Technologies
TT
$106B
$505M 0.2%
3,006,853
+143,068
+5% +$23.6M
IBM icon
109
IBM
IBM
$220B
$498M 0.19%
3,534,469
-205,524
-5% -$28.3M
DD icon
110
DuPont de Nemours
DD
$19.6B
$494M 0.19%
5,738,100
-57,776
-1% -$4.62M
EQIX icon
111
Equinix
EQIX
$105B
$494M 0.19%
754,065
+8,223
+1% +$5.08M
CCI icon
112
Crown Castle
CCI
$32.1B
$491M 0.19%
3,618,421
+175,463
+5% +$23.7M
EL icon
113
Estee Lauder
EL
$31.3B
$490M 0.19%
1,974,065
+217,933
+12% +$48.7M
TGT icon
114
Target
TGT
$66.5B
$482M 0.19%
3,233,321
-58,230
-2% -$9.14M
TMUS icon
115
T-Mobile US
TMUS
$190B
$470M 0.18%
3,359,521
-225,045
-6% -$32.3M
QCOM icon
116
Qualcomm
QCOM
$173B
$469M 0.18%
4,262,220
+826,668
+24% +$96.7M
PH icon
117
Parker-Hannifin
PH
$137B
$452M 0.18%
1,554,720
+29,639
+2% +$8.48M
MSI icon
118
Motorola Solutions
MSI
$77.9B
$452M 0.18%
1,753,456
+95,564
+6% +$23.9M
ANET icon
119
Arista Networks
ANET
$246B
$438M 0.17%
14,444,256
+5,155,632
+56% +$159M
PNC icon
120
PNC Financial Services
PNC
$100B
$437M 0.17%
2,767,423
-16,503
-0.6% -$2.6M
ROP icon
121
Roper Technologies
ROP
$39.3B
$433M 0.17%
1,001,853
-52,689
-5% -$21.7M
BAX icon
122
Baxter International
BAX
$13.8B
$430M 0.17%
8,428,732
+873,951
+12% +$46.9M
AMP icon
123
Ameriprise Financial
AMP
$49.1B
$426M 0.17%
1,367,832
+315,836
+30% +$96.3M
BSX icon
124
Boston Scientific
BSX
$71.5B
$425M 0.16%
9,193,702
-1,359,226
-13% -$58.9M
WCN
125
Waste Connections
WCN
$42.3B
$424M 0.16%
3,196,939
-328,528
-9% -$44.7M

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.